Skip to main content

Tisch Cancer Institute

The Tisch Cancer Institute (TCI) at Mount Sinai is a vital component of the Icahn School of Medicine at Mount Sinai and part of the Mount Sinai Health System, which encompasses eight member hospital campuses across the New York City metropolitan area. Established in 2008 through the generosity of James and Merryl Tisch, TCI was built upon Mount Sinai’s history of distinguished achievements in cancer research and treatment.

In 2015, TCI became an NCI-Designated Cancer Center. The institute’s mission is to advance basic, clinical, and population health cancer research, in order to prevent cancer in healthy individuals and improve the lives of people with cancer and their families in its diverse communities.

Read more about the Tisch Cancer Institute. 

Icahn School of Medicine at Mount Sinai

Clinical
Ramon Parsons, MD, PhD
Director
1 Gustave L. Levy Place
New York, NY 10029
(212) 241-7855
Admin Leader
Sharon Mias, MPA
Executive Administrator
COE Leader
Nina Bickell, MD, MPH
Assoc. Director for Community Engaged and Equity Research
CRTEC Leader
Janice Gabrilove, MD
Assoc. Director for Training and Education

Research Programs

Research Program Program Leaders
Cancer Clinical Investigation Matthew Galsky, MD; Jian Jin, PhD; Samir Parekh, MBBS
Cancer Immunology Nina Bhardwaj, MD, PhD; Miriam Merad, MD, PhD
Cancer Mechanisms Emily Bernstein, PhD; Scott Friedman, MD
Cancer Prevention and Control Jenny Lin, MD, MPH; Emanuela Taioli, MD, PhD

Shared Resources

Category Resource Directors
Cat 1: Laboratory Science Flow Cytometry Jordi Ochando, PhD
Cat 1: Laboratory Science Human Immune Monitoring Center Sacha Gnjatic, PhD; Miriam Merad, MD, PhD
Cat 1: Laboratory Science Microscopy Deanna Benson, PhD
Cat 1: Laboratory Science Mouse Genetics Kevin Kelley, PhD
Cat 6: Biostatistics Biostatistics Madhu Mazumdar, PhD
Last Updated
June 5, 2024